Midostaurin is the 1st New and Approved AML Drug in a Long Time - For patients with FLT3 positive AML in the upfront setting - 100459

Spotlight
Video

Midostaurin is the 1st New and Approved AML Drug in a Long Time - For patients with FLT3 positive AML in the upfront setting

moasc has 332 videos Subscribe Here

Loading........
Description: Deepa Jeyakumar, MD, from UC Irvine Health talks about, Midostaurin, the 1st new and approved AML drug in a long time for patients with FLT3 positive AML in the upfront setting at MOASC’s Spotlight On® Hematology in Huntington Beach.
Shared By : moasc
Posted on : 02/01/18
Added : 8 months ago